Chaponda Mas, Shaukat Adila, Dulli Mohammad Wajeh, Sioufi Stephanie, Al Wali Walid
Infectious Diseases Department, Hamad Medical Corporation, Doha, QAT.
Internal Medicine Department, Hamad Medical Corporation, Doha, QAT.
Cureus. 2022 Oct 15;14(10):e30337. doi: 10.7759/cureus.30337. eCollection 2022 Oct.
Bacterial and fungal coinfections including the emergence of antimicrobial resistance are well-recognized in the era of coronavirus disease 2019 (COVID-19) infections. We present three cases of (EM), superinfections in COVID-19 patients admitted between the period of April 2021 and May 2021. All cases were intubated; had central venous catheters, had received prior antibiotics and antivirals as well as dexamethasone as part of severe COVID-19 management. Only one patient received anakinra. EM isolates were resistant to most available antibiotics and patients infected with it had poor treatment outcomes.
在2019冠状病毒病(COVID-19)感染时代,细菌和真菌合并感染包括抗菌药物耐药性的出现已得到充分认识。我们报告了2021年4月至2021年5月期间收治的3例COVID-19患者发生的坏疽性脓皮病(EM)超级感染病例。所有病例均已插管;有中心静脉导管,作为重症COVID-19治疗的一部分,此前已接受抗生素、抗病毒药物以及地塞米松治疗。只有1例患者接受了阿那白滞素治疗。EM分离株对大多数可用抗生素耐药,感染该菌的患者治疗效果不佳。